Factors Driving Nanoparticle-based Cancer Drug Delivery Systems
Published on 11 Feb, 2016
Conventional options for Cancer treatment are plagued with several issues such as poor water solubility, lack of targeting capability, non-specific distribution, systemic toxicity, and low therapeutic index, to name a few. After some significant advancements made since the late 1960s, Nanoparticles have emerged as promising diagnostic and therapeutic agents for cancer treatment.
Given their size, variety, and inherent flexibility, they can enter tissues at a molecular level and allow therapeutic agents to pass right through biologic barriers.
Several Factors Make Nanoparticles a Superior Drug Delivery System
Perhaps nanoparticles’ greatest advantage is effective targeted drug delivery. The delivery of high drug concentrations to specific receptors minimizes drug-originated systemic toxic effects, significantly reducing toxicity to surrounding normal tissues.
For more information about the use of Nanoparticles and their applications in cancer treatment, check out our report on Nanoparticle Drug Delivery Systems for Cancer Treatment.